Top Stock Movers Now: Ford, Cleveland-Cliffs, Moderna, and More

U.S. equities showed mixed performance midday following China's accusation that the U.S. violated their recent trade agreement, while President Trump's proposal to double steel tariffs to 50% triggered a decline in shares of major automakers like GM, Ford, and Stellantis but boosted U.S. steelmakers such as Cleveland-Cliffs. Moderna shares surged after the FDA approved its new COVID-19 vaccine, and Blueprint Medicines jumped following Sanofi's $9.5 billion acquisition agreement.

Analysis

U.S. equity markets exhibited a mixed performance at midday, influenced by escalating U.S.-China trade tensions after China accused the U.S. of violating a recent trade agreement, a sentiment echoed by President Trump's statement that China had "totally violated" their truce. This geopolitical uncertainty contributed to a 0.5% decline in the Dow Jones Industrial Average and a 0.1% slip in the S&P 500, while the Nasdaq managed a 0.2% gain. Sector-specific impacts were pronounced following President Trump's plan to double tariffs on steel imports to 50%; shares of major U.S. automakers General Motors (GM), Ford (F), and Stellantis (STLA) tumbled. Conversely, U.S. steel producers such as Cleveland-Cliffs (CLF), Steel Dynamics (STLD), and Nucor (NUE) saw their stocks jump on the news. In corporate developments, Moderna (MRNA) shares surged after the FDA approved its new COVID-19 vaccine, mNEXSPIKE, for adults 65 and older and high-risk individuals aged 12-64. Blueprint Medicines (BPMC) shares also experienced a significant uplift following Sanofi's (SNY) agreement to acquire the biopharma firm for up to $9.5 billion. However, Science Applications International Corp. (SAIC) shares dropped as its fiscal 2026 first-quarter profit and free cash flow fell short of analyst expectations. Broader market indicators showed oil and gold futures surging, the 10-year Treasury note yield increasing, and the U.S. dollar weakening against the euro, pound, and yen, while major cryptocurrencies displayed mixed trends. The overall market sentiment is characterized as mixed, with a neutral tone and a moderate market impact score of 0.6, reflecting these divergent catalysts.

Key Decisions for Investors

• Investors should closely monitor developments in U.S.-China trade relations and the proposed steel tariffs, as these present heightened risks for automakers like GM, F, and STLA, but potential upside for domestic steel producers such as CLF, STLD, and NUE.
• The FDA approval for Moderna's mNEXSPIKE and Sanofi's acquisition of Blueprint Medicines highlight event-driven opportunities in the biopharmaceutical sector; thus, evaluating companies with upcoming regulatory milestones or those positioned as M&A targets could be beneficial.
• Given the surge in oil and gold, alongside rising Treasury yields and a weaker U.S. dollar, investors should reassess portfolio allocations for inflation hedging and consider the implications for currency-sensitive assets.
• Scrutinize companies reporting earnings, such as SAIC, for fundamental strength, contrasting underperformers with firms benefiting from specific positive catalysts or M&A activity to identify differentiated investment prospects.